Status:
UNKNOWN
Effects of Ketogenic Diet in Overweight and Obese Women With Breast Cancer
Lead Sponsor:
Necmettin Erbakan University
Conditions:
Breast Cancer Female
Eligibility:
FEMALE
19-64 years
Phase:
NA
Brief Summary
Breast cancer is the most common cancer type among women in Turkey and the world. Chemotherapy, surgery, radiotherapy, immunotherapy and hormone therapy are used in the treatment. Nutrition is one of ...
Detailed Description
The study was designed as a randomized prospective study. The Location of the Research: The research will be carried out in Konya Necmettin Erbakan University Meram Faculty of Medicine, Departments o...
Eligibility Criteria
Inclusion
- Diagnosed with breast cancer for the first time,
- Planned to receive neoadjuvant treatment,
- Being overweight (BMI: 25-29.9 kg/m2) or obese (BMI: ≥30 kg/m2),
- Karnofsky Performance Score ≥ 70
Exclusion
- Ketogenic diet history,
- Diagnosed with moderate/severe neurological and/or cognitive impairment
- Diagnosed with kidney, liver, and gall bladder disease/coronary artery disease
- Diagnosed with type 1 diabetes,
- Diagnosed with type 2 diabetes using oral antidiabetic or insulin,
- Diagnosed with eating behavior disorder (anorexia nervosa, bulimia nervosa, binge eating disorder),
- Using weight loss medication,
- Karnofsky Performance Score \< 70,
- Pregnant
- Breastfeeding individuals
Key Trial Info
Start Date :
January 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2025
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05234502
Start Date
January 30 2022
End Date
January 30 2025
Last Update
February 10 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.